By now, I am sure most of you have heard something about ACEi’s (angiotensin converting enzyme inhibitor) and ARB’s (angiotensin II receptor blockers) with their link to COVID-19. Both of these classes of medications are very widely used all over the world to treat hypertension (high blood pressure), cardiovascular disease, and slow the progression of kidney disease. They are very well tolerated by most people and often have great results with lowering blood pressure.

In light of the recent COVID-19 outbreak, metabolic health is even more important now than ever before. Metabolic syndrome is a cluster of conditions that often occur together and increase your risk of heart disease, stroke, and diabetes.